Sofia Mastoraki

537 total citations
17 papers, 397 citations indexed

About

Sofia Mastoraki is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Sofia Mastoraki has authored 17 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Sofia Mastoraki's work include Cancer Genomics and Diagnostics (10 papers), Epigenetics and DNA Methylation (8 papers) and Advanced Breast Cancer Therapies (3 papers). Sofia Mastoraki is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Epigenetics and DNA Methylation (8 papers) and Advanced Breast Cancer Therapies (3 papers). Sofia Mastoraki collaborates with scholars based in Greece, United States and Poland. Sofia Mastoraki's co-authors include Evi Lianidou, Αreti Strati, Eleni Tzanikou, Martha Zavridou, Maria Chimonidou, Vassilis Georgoulias, Amanda Psyrri, Alexandra Voutsina, Eleni Politaki and Apostolos Klinakis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Sofia Mastoraki

17 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Mastoraki Greece 10 292 216 167 121 36 17 397
Eleni Tzanikou Greece 10 332 1.1× 247 1.1× 192 1.1× 112 0.9× 43 1.2× 11 430
Corinna Keup Germany 11 216 0.7× 173 0.8× 145 0.9× 85 0.7× 17 0.5× 20 308
Daniel C. Bruhm United States 8 163 0.6× 113 0.5× 71 0.4× 70 0.6× 49 1.4× 11 243
Yvonne H. C. M. Smolders Netherlands 5 290 1.0× 140 0.6× 154 0.9× 140 1.2× 82 2.3× 7 350
Lisa Flaum United States 11 299 1.0× 127 0.6× 370 2.2× 207 1.7× 58 1.6× 32 535
Marcin Nicoś Poland 11 157 0.5× 191 0.9× 170 1.0× 164 1.4× 43 1.2× 43 417
Rachel Payne United Kingdom 7 292 1.0× 110 0.5× 267 1.6× 107 0.9× 52 1.4× 8 387
Zi‐Ci Wang China 7 160 0.5× 203 0.9× 158 0.9× 46 0.4× 14 0.4× 8 376
Jiguang Han China 10 214 0.7× 216 1.0× 99 0.6× 70 0.6× 21 0.6× 18 372
Eirini Biziota Greece 8 147 0.5× 151 0.7× 158 0.9× 76 0.6× 29 0.8× 18 319

Countries citing papers authored by Sofia Mastoraki

Since Specialization
Citations

This map shows the geographic impact of Sofia Mastoraki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Mastoraki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Mastoraki more than expected).

Fields of papers citing papers by Sofia Mastoraki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Mastoraki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Mastoraki. The network helps show where Sofia Mastoraki may publish in the future.

Co-authorship network of co-authors of Sofia Mastoraki

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Mastoraki. A scholar is included among the top collaborators of Sofia Mastoraki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Mastoraki. Sofia Mastoraki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Luo, Linjie, Peng Yang, Sofia Mastoraki, et al.. (2025). Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer. SHILAP Revista de lepidopterología. 24(1). 48–48. 7 indexed citations
2.
Li, Mi, Amriti R. Lulla, Spyros Tsavachidis, et al.. (2024). Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer. Cancer Research. 84(22). 3864–3880. 4 indexed citations
3.
Markou, Athina, Αreti Strati, Martha Zavridou, et al.. (2023). Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer. Scientific Reports. 13(1). 1258–1258. 37 indexed citations
4.
Luo, Linjie, Yan Wang, Sofia Mastoraki, et al.. (2023). Abstract 4346: TFF1 and TFF3 predict response to CDK4/6 inhibitors in breast cancer patients. Cancer Research. 83(7_Supplement). 4346–4346. 1 indexed citations
5.
Lulla, Amriti R., Tuyen Duong Thanh Nguyen, Mi Li, et al.. (2023). Abstract 950: Targeting PKMYT1 kinase is an effective treatment strategy in triple negative breast cancers with low molecular weight cyclin E (LMW-E) expression. Cancer Research. 83(7_Supplement). 950–950. 3 indexed citations
6.
Akli, Saïd, Amriti R. Lulla, Natalie W. Fowlkes, et al.. (2022). Abstract 2592: Aurora kinase is an actionable target in low molecular weight cyclin E induced mammary tumors. Cancer Research. 82(12_Supplement). 2592–2592. 1 indexed citations
7.
Mastoraki, Sofia, Evangelos Bournakis, Martha Zavridou, et al.. (2021). USP44 Promoter Methylation in Plasma Cell-Free DNA in Prostate Cancer. Cancers. 13(18). 4607–4607. 11 indexed citations
8.
Mastoraki, Sofia, Ioanna Balgkouranidou, Emily Tsaroucha, et al.. (2020). KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer. Molecular Oncology. 15(9). 2412–2422. 26 indexed citations
9.
Zavridou, Martha, Sofia Mastoraki, Αreti Strati, et al.. (2020). Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma. Scientific Reports. 10(1). 6551–6551. 40 indexed citations
10.
Markou, Athina, Eleni Tzanikou, Αreti Strati, et al.. (2020). PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients. Cancers. 12(5). 1188–1188. 14 indexed citations
11.
Strati, Αreti, Martha Zavridou, Evangelos Bournakis, Sofia Mastoraki, & Evi Lianidou. (2019). Expression pattern of androgen receptors, AR-V7 and AR-567es, in circulating tumor cells and paired plasma-derived extracellular vesicles in metastatic castration resistant prostate cancer. The Analyst. 144(22). 6671–6680. 20 indexed citations
12.
Giannopoulou, Lydia, Sofia Mastoraki, Paul Buderath, et al.. (2018). ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer. Gynecologic Oncology. 150(2). 355–360. 46 indexed citations
13.
Zavridou, Martha, Sofia Mastoraki, Αreti Strati, et al.. (2018). Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies. Clinical Chemistry. 64(10). 1522–1533. 44 indexed citations
14.
Mastoraki, Sofia, Αreti Strati, Eleni Tzanikou, et al.. (2017). ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment. Clinical Cancer Research. 24(6). 1500–1510. 126 indexed citations
15.
Giannopoulou, Lydia, et al.. (2017). Abstract 5691: ESR1 methylation in plasma cfDNA of patients with high-grade serous ovarian cancer. Cancer Research. 77(13_Supplement). 5691–5691. 1 indexed citations
16.
Parisi, Cleo, Sofia Mastoraki, Athina Markou, et al.. (2016). Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis. Clinica Chimica Acta. 461. 156–164. 11 indexed citations
17.
Mastoraki, Sofia, Maria Chimonidou, Sophia Kounelis, et al.. (2015). A rapid and accurate closed-tube Methylation-Sensitive High Resolution Melting Analysis assay for the semi-quantitative determination of SOX17 promoter methylation in clinical samples. Clinica Chimica Acta. 444. 303–309. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleni Tzanikou Breakdown of academic impact, for papers by Corinna Keup Breakdown of academic impact, for papers by Daniel C. Bruhm Breakdown of academic impact, for papers by Yvonne H. C. M. Smolders Breakdown of academic impact, for papers by Lisa Flaum Breakdown of academic impact, for papers by Marcin Nicoś Breakdown of academic impact, for papers by Rachel Payne Breakdown of academic impact, for papers by Zi‐Ci Wang Breakdown of academic impact, for papers by Jiguang Han Breakdown of academic impact, for papers by Eirini Biziota
Rankless by CCL
2026